A rare histiocytosis whose first-ever genome-wide study found one germline risk variant near SETBP1 — a gene otherwise known for its role in clonal blood-cell mutation.
Erdheim-Chester disease (ECD) is a rare histiocytosis (a disorder of the immune system's histiocyte cells) with wide-ranging clinical presentations. Until recently, its known genetic drivers were entirely somatic — mutations that arise in the affected cells themselves, not inherited ones. This page covers the one variant on this site from the study that changed that picture.
A 2024 study in Arthritis & Rheumatology ran the first genome-wide association study of ECD ever conducted, comparing 255 people with ECD against 7,471 healthy donors. It found one genome-wide-significant susceptibility locus at chromosome 18q12.3 (P=2.75×10-11, odds ratio 2.09) — rs188050966, annotated to the SETBP1 gene.
SETBP1 is independently known for its involvement in clonal haematopoiesis — the process by which a single blood-forming stem cell's descendants come to dominate blood production, which is separately implicated in ECD's somatic mutation profile. Finding a germline (inherited) variant near the same gene suggests inherited risk and the disease's known somatic drivers may point at overlapping biology, rather than being two unrelated processes.
Erdheim-Chester disease is diagnosed through tissue biopsy and imaging, not by genotype. This variant is a single germline risk signal from the first study of its kind — not a diagnostic marker, and not a substitute for the somatic-mutation testing (e.g. BRAF) already used clinically.
Before this 2024 study, ECD's genetic story was told entirely through mutations acquired within diseased cells. This is the first evidence that inherited variation plays a role too — the study's authors frame it as suggesting new pathogenic pathways to investigate, not as a finished explanation.
What a 23andMe/AncestryDNA export or raw VCF can and can't tell you about Erdheim-Chester Disease comes down to these specific, well-studied positions — not a diagnosis.
Databases, guidelines and references
Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.
Erdheim-Chester Disease. MyGeneLog™. https://www.mygenelog.com/conditions/erdheim-chester-disease
Erdheim-Chester disease (ECD) is a rare histiocytosis — a disorder of the immune system’s histiocyte cells — with a wide range of possible clinical manifestations.
A 2024 study — the first genome-wide association study of ECD — found the first evidence of germline (inherited) genetic risk, a susceptibility locus near the SETBP1 gene. Before this, ECD’s known genetic drivers were entirely somatic (arising within the diseased cells themselves).
SETBP1 is a gene independently known for its role in clonal haematopoiesis. Its appearance in this GWAS suggests a possible link between inherited risk and ECD’s already-known somatic mutation biology.
Free to reuse. This page's text is original writing from freely-available research, licensed CC BY 4.0 — reuse it, including commercially, with attribution to MyGeneLog™. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.